Science is justly admired as a cumulative process ("standing on the shoulders of giants"), yet scientific knowledge is typically built on a patchwork of research contributions without much coordination. This lack of efficiency has specifically been addressed in clinical research by recommendations against avoidable research waste and for living systematic reviews and prospective meta-analysis. We propose to further those recommendations with ALL-IN meta-analysis: Anytime Live and Leading INterim meta-analysis. ALL-IN provides meta-analysis based on e-values and anytime-valid confidence intervals that can be updated at any time - reanalyzing after each new observation while retaining type-I error and coverage guarantees, live - no need to prespecify the looks, and leading - in the decisions on whether individual studies should be initiated, stopped or expanded, the meta-analysis can be the leading source of information without losing validity to accumulation bias. The analysis design requires no information about the trial sample sizes or the number of trials eventually included. So ALL-IN meta-analysis can be applied retrospectively as well as prospectively, to evaluate the evidenc
使用 AI 将内容摘要翻译为中文,便于快速阅读
使用 AI 分析这篇文章的核心发现、关键要点和深度见解
由 DeepSeek AI 提供分析 · 首次使用需配置 API Key